Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Stock analysts at Cormark reduced their FY2024 EPS estimates for Cresco Labs in a research report issued on Monday, November 11th. Cormark analyst J. Pytlak now anticipates that the company will post earnings of ($0.21) per share for the year, down from their prior estimate of ($0.17). Cormark currently has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Cormark also issued estimates for Cresco Labs’ FY2025 earnings at $0.03 EPS.
Several other research firms have also recently weighed in on CRLBF. Needham & Company LLC restated a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Roth Capital upgraded shares of Cresco Labs to a “strong-buy” rating in a research report on Sunday, November 10th. Finally, Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a research report on Friday, August 9th. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $2.50.
Cresco Labs Stock Down 2.8 %
Shares of OTCMKTS CRLBF opened at $1.40 on Thursday. Cresco Labs has a 1 year low of $1.02 and a 1 year high of $2.65. The company has a market capitalization of $683.40 million, a price-to-earnings ratio of -7.20 and a beta of 1.88. The company has a debt-to-equity ratio of 1.76, a current ratio of 2.00 and a quick ratio of 1.30. The business has a 50-day moving average of $1.58 and a two-hundred day moving average of $1.70.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
- Five stocks we like better than Cresco Labs
- What is a SEC Filing?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to buy stock: A step-by-step guide for beginners
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.